Chronic anemia is a persistent drop in red blood cells or hemoglobin that lasts weeks to months, rather than resolving on its own. Unlike anemia from a sudden injury or short-term illness, chronic anemia develops gradually and often signals an underlying condition that keeps the body from producing or maintaining enough healthy red blood cells. It affects millions of people worldwide, frequently alongside diseases like kidney disease, autoimmune disorders, and cancer.
How Chronic Anemia Differs From Short-Term Anemia
All anemia involves hemoglobin levels falling below a healthy threshold. For adult men, that threshold is roughly 135 g/L; for non-pregnant adult women, it’s about 120 g/L. In children, the numbers shift with age, ranging from around 104 g/L in infants to 114 g/L in school-age kids. What makes anemia “chronic” isn’t a different hemoglobin number. It’s the duration and the reason behind it.
Acute anemia happens fast, often from blood loss during surgery or trauma, and resolves once the cause is treated. Chronic anemia persists because the underlying driver, whether it’s ongoing inflammation, a failing kidney, or a nutrient absorption problem, hasn’t been corrected. Your body adapts to the lower oxygen delivery over time, which is why many people with chronic anemia don’t feel a dramatic crash. Instead, symptoms creep in slowly and become a new, diminished normal.
What Causes It
The most common form is sometimes called anemia of chronic disease. It develops when a long-standing illness triggers ongoing inflammation in the body, and that inflammation interferes with how your body handles iron. The key player is a hormone called hepcidin, produced by the liver. When inflammation is present, hepcidin levels rise sharply. High hepcidin blocks iron from being absorbed in the gut and locks existing iron stores inside cells, keeping it out of the bloodstream where it’s needed to build new red blood cells. Your body may actually have plenty of iron in storage, but it can’t access it.
The conditions most often responsible include:
- Autoimmune diseases like rheumatoid arthritis and lupus
- Chronic kidney disease (CKD), which also reduces the hormone that signals your bone marrow to make red blood cells
- Cancer, which can cause anemia through inflammation, blood loss, or direct damage to bone marrow
- Chronic infections such as HIV/AIDS and tuberculosis
- Inflammatory bowel disease, including Crohn’s disease and ulcerative colitis
- Heart failure and diabetes, both of which involve low-grade systemic inflammation
Iron deficiency itself is another major driver, particularly when it’s caused by ongoing blood loss (heavy periods, gastrointestinal bleeding) or poor absorption from conditions like celiac disease. Some people have both: true iron deficiency layered on top of inflammation-driven anemia, which complicates diagnosis and treatment.
What It Feels Like Over Time
Because chronic anemia develops slowly, early symptoms are easy to dismiss. Fatigue is the hallmark, but not ordinary tiredness. It’s the kind that doesn’t improve with sleep, makes climbing a flight of stairs feel disproportionately hard, and narrows the range of activities you can manage in a day. Pale skin, cold hands and feet, shortness of breath during mild exertion, and dizziness on standing are all common.
Some people notice difficulty concentrating, brain fog, or irritability. These cognitive effects aren’t just from feeling tired. When hemoglobin drops, less oxygen reaches the brain, and over months to years this can cause measurable changes. Research has linked chronic anemia, even in milder forms, to silent brain infarcts and white matter lesions. These are small areas of damage detectable on brain scans that serve as precursors to cognitive decline, particularly in older adults. Long-term cerebral oxygen deprivation can progress from mild cognitive impairment to more severe forms of dementia.
The heart takes a hit too. To compensate for reduced oxygen-carrying capacity, the heart pumps harder and faster. Over time, this extra workload can cause the heart’s left ventricle to thicken and enlarge. Chronic anemia also promotes inflammation in blood vessel walls, disrupting their normal function and accelerating atherosclerosis. This is one reason untreated anemia in people with existing heart or kidney disease worsens outcomes so dramatically.
How Doctors Identify the Cause
A standard blood count will confirm anemia, but finding out why it’s chronic takes more digging. The challenge is that common lab markers can be misleading when inflammation is involved. Ferritin, the most widely used measure of iron stores, is a good example. In a healthy person, ferritin below 30 μg/L reliably indicates iron deficiency. But ferritin is also an inflammation marker, so it rises during chronic disease regardless of how much iron is actually available. Someone with rheumatoid arthritis or kidney disease could have a ferritin of 150 μg/L and still be functionally iron-deficient.
To work around this, doctors use different cutoffs for people with inflammatory conditions. Iron deficiency is suspected when ferritin falls below 100 μg/L, or when transferrin saturation (a measure of how much iron is actively circulating) drops below 20%. When ferritin lands in an ambiguous range between 100 and 300 μg/L, the transferrin saturation test becomes the tiebreaker.
A newer marker, reticulocyte hemoglobin content, measures how much hemoglobin is packed into the youngest red blood cells your body just produced. Because these cells are only a day or two old, their hemoglobin level reflects real-time iron availability rather than stored reserves. It’s particularly useful in kidney disease patients, where standard markers often give contradictory signals.
Treatment Depends on the Underlying Cause
There’s no single fix for chronic anemia because the treatment has to address what’s driving it. Managing the underlying condition, whether that’s controlling inflammation in autoimmune disease, treating an infection, or stabilizing kidney function, is always the first priority. When inflammation decreases, hepcidin levels fall, and the body regains access to its iron stores.
Iron supplementation is straightforward in concept but tricky in practice. Oral iron tablets work well for mild to moderate iron deficiency in people without significant inflammation. But when chronic disease keeps hepcidin elevated, oral iron gets blocked at the gut wall and barely reaches the bloodstream. In these cases, intravenous iron bypasses the absorption problem entirely. Studies consistently show IV iron produces larger hemoglobin increases than oral iron in patients with CKD, inflammatory bowel disease, and cancer-related anemia. The infusion itself typically takes 15 to 30 minutes in a clinic, and many people notice improved energy within a couple of weeks.
For people with chronic kidney disease, the kidneys no longer produce enough of the hormone that tells bone marrow to make red blood cells. Synthetic versions of that hormone, given as injections, have been a mainstay treatment for decades. A newer class of oral medications works differently: instead of replacing the missing hormone directly, these drugs stabilize a protein called HIF that naturally orchestrates the entire red-blood-cell production process. They boost the body’s own hormone production, increase iron absorption, and lower hepcidin all at once. The first of these, roxadustat, was approved in 2018 for kidney-related anemia, and several others have followed. They’re also being studied for cancer-related anemia.
Living With Chronic Anemia
Many people with chronic anemia manage it as one piece of a larger health picture. Regular blood work, typically every few months, helps track whether hemoglobin is stable, improving, or slipping. Knowing your own baseline matters because a hemoglobin of 110 g/L might be someone’s well-managed normal while the same number in someone else signals a problem.
Diet plays a supporting role but rarely solves the problem alone when chronic disease is involved. Iron-rich foods (red meat, lentils, spinach, fortified cereals) help, and pairing them with vitamin C improves absorption. But if hepcidin is blocking iron uptake at a hormonal level, no amount of dietary adjustment will fully compensate. That said, nutritional deficiencies in B12 or folate can layer on top of chronic disease anemia, so correcting those gaps still matters.
Fatigue management is practical, not just medical. Pacing activities, prioritizing sleep, and building in rest periods aren’t signs of giving in. They’re strategies that preserve quality of life while treatment works on the underlying numbers. Light exercise, when tolerated, actually improves oxygen efficiency and can reduce the sensation of fatigue over time, even before hemoglobin fully recovers.